Pancreatic Cancer Research

ResearcherThe University of MelbourneNo recent work listed

Kai Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0567-3004; OpenAlex author ID A5100774874. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stroma. Co-author PMID 37193135↗
  2. The PAK Inhibitor PF-3758309 Promotes the Inhibitory Effects of Multiple Chemotherapeutic Reagents on Patient-Derived Pancreatic Cancer Cell Lines Co-author DOI 10.20944/preprints201809.0322.v1↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hong Zhen He · 2 shared papers, 2018–2023 · strength 0.27
  2. Mehrdad Nikfarjam · 2 shared papers, 2018–2023 · strength 0.27
  3. Ching‐Seng Ang · 1 shared paper, 2023 · strength 0.18
  4. Yi Ma · 1 shared paper, 2023 · strength 0.18
  5. Nien‐Hung Lee · 1 shared paper, 2023 · strength 0.18
  6. Ashleigh Parkin · 1 shared paper, 2018 · strength 0.08
  7. Jennifer Man · 1 shared paper, 2018 · strength 0.08
  8. Marina Pajic · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.